These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


290 related items for PubMed ID: 26315541

  • 21. Inhibition of cell proliferation and metastasis of human hepatocellular carcinoma by miR-137 is regulated by CDC42.
    Gao M, Liu L, Li S, Zhang X, Chang Z, Zhang M.
    Oncol Rep; 2015 Nov; 34(5):2523-32. PubMed ID: 26352279
    [Abstract] [Full Text] [Related]

  • 22. MicroRNA-455 regulates migration and invasion of human hepatocellular carcinoma by targeting Runx2.
    Qin L, Zhang Y, Lin J, Shentu Y, Xie X.
    Oncol Rep; 2016 Dec; 36(6):3325-3332. PubMed ID: 27748890
    [Abstract] [Full Text] [Related]

  • 23. miR-613 inhibits the growth and invasiveness of human hepatocellular carcinoma via targeting DCLK1.
    Wang W, Zhang H, Wang L, Zhang S, Tang M.
    Biochem Biophys Res Commun; 2016 May 13; 473(4):987-992. PubMed ID: 27049311
    [Abstract] [Full Text] [Related]

  • 24. MicroRNA-214 downregulation contributes to tumor angiogenesis by inducing secretion of the hepatoma-derived growth factor in human hepatoma.
    Shih TC, Tien YJ, Wen CJ, Yeh TS, Yu MC, Huang CH, Lee YS, Yen TC, Hsieh SY.
    J Hepatol; 2012 Sep 13; 57(3):584-91. PubMed ID: 22613005
    [Abstract] [Full Text] [Related]

  • 25. Upregulated in Hepatitis B virus-associated hepatocellular carcinoma cells, miR-331-3p promotes proliferation of hepatocellular carcinoma cells by targeting ING5.
    Cao Y, Chen J, Wang D, Peng H, Tan X, Xiong D, Huang A, Tang H.
    Oncotarget; 2015 Nov 10; 6(35):38093-106. PubMed ID: 26497554
    [Abstract] [Full Text] [Related]

  • 26. MicroRNA-340 inhibits the proliferation and invasion of hepatocellular carcinoma cells by targeting JAK1.
    Yuan J, Ji H, Xiao F, Lin Z, Zhao X, Wang Z, Zhao J, Lu J.
    Biochem Biophys Res Commun; 2017 Jan 29; 483(1):578-584. PubMed ID: 27998770
    [Abstract] [Full Text] [Related]

  • 27. miR-122 regulates tumorigenesis in hepatocellular carcinoma by targeting AKT3.
    Nassirpour R, Mehta PP, Yin MJ.
    PLoS One; 2013 Jan 29; 8(11):e79655. PubMed ID: 24244539
    [Abstract] [Full Text] [Related]

  • 28. MicroRNA-375 targets AEG-1 in hepatocellular carcinoma and suppresses liver cancer cell growth in vitro and in vivo.
    He XX, Chang Y, Meng FY, Wang MY, Xie QH, Tang F, Li PY, Song YH, Lin JS.
    Oncogene; 2012 Jul 12; 31(28):3357-69. PubMed ID: 22056881
    [Abstract] [Full Text] [Related]

  • 29. MiR-195 is a key negative regulator of hepatocellular carcinoma metastasis by targeting FGF2 and VEGFA.
    Wang M, Zhang J, Tong L, Ma X, Qiu X.
    Int J Clin Exp Pathol; 2015 Jul 12; 8(11):14110-20. PubMed ID: 26823724
    [Abstract] [Full Text] [Related]

  • 30. MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer.
    Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, Patel T.
    Gastroenterology; 2007 Aug 12; 133(2):647-58. PubMed ID: 17681183
    [Abstract] [Full Text] [Related]

  • 31. Overexpression of miR-218 inhibits hepatocellular carcinoma cell growth through RET.
    Sui C, Xu F, Shen W, Geng L, Xie F, Dai B, Lu J, Zhang M, Yang J.
    Tumour Biol; 2015 Mar 12; 36(3):1511-8. PubMed ID: 25374061
    [Abstract] [Full Text] [Related]

  • 32. Comprehensive N-glycan profiles of hepatocellular carcinoma reveal association of fucosylation with tumor progression and regulation of FUT8 by microRNAs.
    Cheng L, Gao S, Song X, Dong W, Zhou H, Zhao L, Jia L.
    Oncotarget; 2016 Sep 20; 7(38):61199-61214. PubMed ID: 27533464
    [Abstract] [Full Text] [Related]

  • 33. Regulation of Tumorigenesis in Hepatocellular Carcinoma via the AKT3 Pathway in Cell Lines.
    Xing M, Xie X, Liu Z, Du X.
    Comput Math Methods Med; 2021 Sep 20; 2021():3267536. PubMed ID: 34745324
    [Abstract] [Full Text] [Related]

  • 34. Expression profile of microRNA-200 family in hepatocellular carcinoma with bile duct tumor thrombus.
    Yeh TS, Wang F, Chen TC, Yeh CN, Yu MC, Jan YY, Chen MF.
    Ann Surg; 2014 Feb 20; 259(2):346-54. PubMed ID: 24135722
    [Abstract] [Full Text] [Related]

  • 35. The putative tumour suppressor microRNA-124 modulates hepatocellular carcinoma cell aggressiveness by repressing ROCK2 and EZH2.
    Zheng F, Liao YJ, Cai MY, Liu YH, Liu TH, Chen SP, Bian XW, Guan XY, Lin MC, Zeng YX, Kung HF, Xie D.
    Gut; 2012 Feb 20; 61(2):278-89. PubMed ID: 21672940
    [Abstract] [Full Text] [Related]

  • 36. MicroRNA-7 inhibits tumor growth and metastasis by targeting the phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
    Fang Y, Xue JL, Shen Q, Chen J, Tian L.
    Hepatology; 2012 Jun 20; 55(6):1852-62. PubMed ID: 22234835
    [Abstract] [Full Text] [Related]

  • 37. Hepatocellular carcinoma-associated mesenchymal stem cells promote hepatocarcinoma progression: role of the S100A4-miR155-SOCS1-MMP9 axis.
    Yan XL, Jia YL, Chen L, Zeng Q, Zhou JN, Fu CJ, Chen HX, Yuan HF, Li ZW, Shi L, Xu YC, Wang JX, Zhang XM, He LJ, Zhai C, Yue W, Pei XT.
    Hepatology; 2013 Jun 20; 57(6):2274-86. PubMed ID: 23316018
    [Abstract] [Full Text] [Related]

  • 38. MicroRNA-338-3p inhibits cell proliferation in hepatocellular carcinoma by target forkhead box P4 (FOXP4).
    Wang G, Sun Y, He Y, Ji C, Hu B, Sun Y.
    Int J Clin Exp Pathol; 2015 Jun 20; 8(1):337-44. PubMed ID: 25755720
    [Abstract] [Full Text] [Related]

  • 39. MicroRNA-4317 suppresses the progression of hepatocellular carcinoma by targeting ZNF436-mediated PI3K/AKT signaling pathway.
    Zhang L, Chang S, Zhao Y, Cao G, Zhang D.
    Tissue Cell; 2022 Feb 20; 74():101696. PubMed ID: 34861581
    [Abstract] [Full Text] [Related]

  • 40. In hepatocellular carcinoma miR-519d is up-regulated by p53 and DNA hypomethylation and targets CDKN1A/p21, PTEN, AKT3 and TIMP2.
    Fornari F, Milazzo M, Chieco P, Negrini M, Marasco E, Capranico G, Mantovani V, Marinello J, Sabbioni S, Callegari E, Cescon M, Ravaioli M, Croce CM, Bolondi L, Gramantieri L.
    J Pathol; 2012 Jul 20; 227(3):275-85. PubMed ID: 22262409
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 15.